Galderma: Combined Use of Rosacea Therapies Ivermectin 1% Cream and Brimonidine 0.33% Gel Evaluated in MOSAIC Study

PR69995

LAUSANNE, Switzerland, Sept. 11, 2017/PRNewswire=KYODO JBN/ --

    Today, the results of a study evaluating the combined use of topical

rosacea treatments ivermectin 1% cream and brimonidine 0.33% gel were published

in the Journal of Drugs in Dermatology.

    (Logo: http://mma.prnewswire.com/media/554005/Galderma_Logo.jpg )

    "This is the first study evaluating the benefit of using both ivermectin 1%

and brimonidine 0.33% in combination to effectively target the multiple

features of rosacea," commented study author Linda Stein Gold, Henry Ford

Hospital, Detroit, MI. "This study develops a comprehensive and early treatment

approach to this complex disease."

    "The visible signs of rosacea can significantly impact patients' quality of

life," said Gregor Schaefer, Medical Lead at Galderma. "Galderma is committed

to supporting patients through the development of practical treatment options."

    Reference:

    Stein Gold L, et al. J Drugs Dermatol. 2017;16(9):909-916.

    About Rosacea

    Rosacea is a common inflammatory skin disease that presents variable

clinical characteristics, of which the most common are flushing, permanent

erythema, and inflammatory lesions. It mainly affects the central areas of the

face, such as the cheeks and nose. The disease can affect both adult men and

women, usually after the age of 30. Additionally, symptoms such as stinging,

burning and increased sensitivity of the skin are common. The eyes are often

affected, and might present as red, dry or itchy.

    Although the cause of the disease is still under debate, various trigger

factors are known, including spicy foods, alcohol, emotional stress,

sun/UV-exposure, hot baths and beverages. Demodex, generally harmless mites,

can also be found in the skin in an elevated quantity in people with rosacea.

    Rosacea may worsen over time if left untreated. People that suspect they

suffer from rosacea should visit their dermatologist or healthcare provider for

diagnosis and discuss what treatment is right for them. Because rosacea is a

highly visible disease, it is known to cause embarrassment and anxiety in some

patients, which in turn may cause frustration and have a negative impact on

their social life.

    About Galderma

    Galderma, Nestlé Skin Health's medical solutions business, was created in

1981 and is now present in over 100 countries with an extensive product

portfolio to treat a range of dermatological conditions. The company partners

with health care practitioners around the world to meet the skin health needs

of people throughout their lifetime. Galderma is a leader in research and

development of scientifically defined and medically proven solutions for the

skin, hair and nails. For more information, please visit http://www.galderma.com

    Source: Galderma